The Mainland China share market eked out modest gains on Monday, 10 May 2021, as gains in energy and healthcare companies were more than offset by losses in tech shares. At closing bell, the benchmark Shanghai Composite Index was up 0.27%, or 9.12 points, to 3,427.99. The Shenzhen Composite Index, which tracks stocks on China's second exchange, added 0.19%, or 4.25 points, to 2,243.93. The blue-chip CSI300 index fell 0.07%, or 3.63 points, to 4,992.42.
Shares of healthcare companies advanced after a U. S. proposal to waive patents for Covid-19 vaccines met with fierce opposition from European governments and pharmaceutical giants.
Cansino Biologics rallied 8.5% to 480.50 yuan
Shares of Shanghai Fosun Pharmaceutical Group surged by the 10% daily limit to 60.12 yuan after the drugmaker a unit will form a venture with Germany-based BioNTech to build a plant in China capable of producing 1 billion doses of Covid-19 vaccines a year.
Energy shares CNOOC and PetroChina rose, as crude oil futures rose on concern about disruption of supplies after cyber attack shut down a U. S. pipeline operator that provides nearly half of the U. S. east coast's fuel supply.
Shares of tech companies declined after the internet watchdog on Saturday announced a ban on some mobile app notifications, as regulators ramp up a campaign to rein in internet firms' growing influence.
CURRENCY NEWS: China yuan appreciated to a 3-1/2-month high against the dollar on Monday, inline with softer mid-point fixing by central bank. Prior to market opening, the People's Bank of China (PBOC) lifted the midpoint rate CNY=PBOC by the most since early January to 6.4425 per dollar, 253 pips firmer than the previous fix of 6.4678. In the spot market, the onshore yuan CNY=CFXS opened at 6.4320 per dollar and rose to a high of 6.4265, the firmest since Jan. 29. By midday, it was changing hands at 6.4295, 13 pips firmer than the previous late session close.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU